{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:53:22Z","timestamp":1773449602070,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbih.2025.101085","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:53:29Z","timestamp":1753919609000},"page":"101085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Detection of autoantibodies against Interferon Type I in patients with autochthonous West Nile Virus encephalitis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-2641","authenticated-orcid":false,"given":"Jan","family":"Braune","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz","family":"Pechstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Melchert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Max","family":"Corman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiana","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2025.101085_bib1","series-title":"Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I-interferon auto-antibodies by an Easily Implementable Algorithm","author":"Akbil","year":"2021"},{"issue":"62","key":"10.1016\/j.bbih.2025.101085_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.bbih.2025.101085_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/ijmr.IJMR_642_19","article-title":"Global emergence of west nile virus: threat & preparedness in special perspective to India","volume":"154","author":"Chowdhury","year":"2021","journal-title":"Indian J. Med. Res."},{"issue":"9","key":"10.1016\/j.bbih.2025.101085_bib5","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230661","article-title":"Autoantibodies neutralizing type I IFNs underlie west nile virus encephalitis in \u223c40% of patients","volume":"220","author":"Gervais","year":"2023","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.bbih.2025.101085_bib6","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240942","article-title":"Auto-Abs neutralizing type I IFNs in patients with severe powassan, usutu, or ross river virus disease","volume":"221","author":"Gervais","year":"2024","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbih.2025.101085_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1471-2334-14-248","article-title":"West nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes","volume":"14","author":"Hart","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.bbih.2025.101085_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1474-4422(07)70030-3","article-title":"West Nile virus","volume":"6","author":"Kramer","year":"2007","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bbih.2025.101085_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41600-3","article-title":"Blockade of interferon signaling decreases gut barrier integrity and promotes severe West Nile virus disease","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.bbih.2025.101085_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150867","article-title":"Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1","volume":"131","author":"Meisel","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"24","key":"10.1016\/j.bbih.2025.101085_bib11","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","article-title":"The outbreak of West Nile virus infection in the New York City area in 1999","volume":"344","author":"Nash","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbih.2025.101085_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/jama.2013.8042","article-title":"West Nile virus: review of the literature","volume":"310","author":"Petersen","year":"2013","journal-title":"JAMA"},{"issue":"6\u20137","key":"10.1016\/j.bbih.2025.101085_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/00365540410020659","article-title":"High-Dose steroids in the management of acute flaccid paralysis due to West Nile virus infection","volume":"36","author":"Pyrgos","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.bbih.2025.101085_bib15","unstructured":"Robert-Koch-Institut. Survstat [Available from: https:\/\/survstat.rki.de\/Content\/Query\/Create.aspx."},{"issue":"48","key":"10.1016\/j.bbih.2025.101085_bib16","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.48.2300258","article-title":"Ecological and clinical evidence of the establishment of West Nile virus in a large urban area in Europe, Berlin, Germany, 2021 to 2022","volume":"28","author":"Ruscher","year":"2023","journal-title":"Euro Surveill."},{"issue":"Pt 6","key":"10.1016\/j.bbih.2025.101085_bib17","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1099\/vir.0.000079","article-title":"Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis","volume":"96","author":"Srivastava","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbih.2025.101085_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268822000887","article-title":"Comorbid conditions as risk factors for West Nile neuroinvasive disease in Ontario, Canada: a population-based cohort study","volume":"150","author":"Sutinen","year":"2022","journal-title":"Epidemiol. Infect."},{"issue":"11","key":"10.1016\/j.bbih.2025.101085_bib19","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220514","article-title":"Autoantibodies against type I IFNs in patients with critical influenza pneumonia","volume":"219","author":"Zhang","year":"2022","journal-title":"J. Exp. Med."}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354625001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:21:20Z","timestamp":1772918480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354625001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":17,"alternative-id":["S2666354625001437"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101085","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of autoantibodies against Interferon Type I in patients with autochthonous West Nile Virus encephalitis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2025.101085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101085"}}